nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibuprofen—osteoarthritis—Prednisone—ankylosing spondylitis	0.257	0.5	CpDpCtD
Ibuprofen—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.257	0.5	CpDpCtD
Ibuprofen—PPARG—Sulfasalazine—ankylosing spondylitis	0.0776	0.202	CbGbCtD
Ibuprofen—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0239	0.0622	CbGbCtD
Ibuprofen—PTGS2—Triamcinolone—ankylosing spondylitis	0.0232	0.0602	CbGbCtD
Ibuprofen—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0232	0.0602	CbGbCtD
Ibuprofen—SLCO1A2—Prednisone—ankylosing spondylitis	0.0226	0.0588	CbGbCtD
Ibuprofen—PTGS2—Betamethasone—ankylosing spondylitis	0.0199	0.0517	CbGbCtD
Ibuprofen—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0196	0.0509	CbGbCtD
Ibuprofen—SLC22A11—Methotrexate—ankylosing spondylitis	0.017	0.0442	CbGbCtD
Ibuprofen—ABCC4—Methotrexate—ankylosing spondylitis	0.0158	0.0411	CbGbCtD
Ibuprofen—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0141	0.0367	CbGbCtD
Ibuprofen—ABCC1—Methotrexate—ankylosing spondylitis	0.0127	0.033	CbGbCtD
Ibuprofen—ALB—Prednisone—ankylosing spondylitis	0.0117	0.0304	CbGbCtD
Ibuprofen—PTGS2—Dexamethasone—ankylosing spondylitis	0.0116	0.0301	CbGbCtD
Ibuprofen—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0113	0.0295	CbGbCtD
Ibuprofen—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0101	0.0262	CbGbCtD
Ibuprofen—SLC22A8—Methotrexate—ankylosing spondylitis	0.00988	0.0257	CbGbCtD
Ibuprofen—CYP2C19—Prednisone—ankylosing spondylitis	0.00757	0.0197	CbGbCtD
Ibuprofen—SLC22A6—Methotrexate—ankylosing spondylitis	0.00688	0.0179	CbGbCtD
Ibuprofen—ABCB1—Betamethasone—ankylosing spondylitis	0.00656	0.017	CbGbCtD
Ibuprofen—ABCB1—Prednisolone—ankylosing spondylitis	0.00647	0.0168	CbGbCtD
Ibuprofen—ABCB1—Prednisone—ankylosing spondylitis	0.00611	0.0159	CbGbCtD
Ibuprofen—ALB—Methotrexate—ankylosing spondylitis	0.00586	0.0152	CbGbCtD
Ibuprofen—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00564	0.0147	CbGbCtD
Ibuprofen—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00473	0.0123	CbGbCtD
Ibuprofen—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00393	0.0102	CbGbCtD
Ibuprofen—ABCB1—Dexamethasone—ankylosing spondylitis	0.00381	0.00992	CbGbCtD
Ibuprofen—ABCB1—Methotrexate—ankylosing spondylitis	0.00307	0.00797	CbGbCtD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.00143	0.062	CbGpPWpGaD
Ibuprofen—PLAT—Orphan transporters—ANO6—ankylosing spondylitis	0.00109	0.0473	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.000858	0.0372	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—CREG1—ankylosing spondylitis	0.000824	0.0357	CbGpPWpGaD
Ibuprofen—PLAT—Endochondral Ossification—RUNX3—ankylosing spondylitis	0.000668	0.029	CbGpPWpGaD
Ibuprofen—PLAT—Beta2 integrin cell surface interactions—CD40LG—ankylosing spondylitis	0.000622	0.027	CbGpPWpGaD
Ibuprofen—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.000618	0.0268	CbGpPWpGaD
Ibuprofen—CFTR—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000546	0.0237	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.000442	0.0191	CbGpPWpGaD
Ibuprofen—BCL2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.00044	0.0191	CbGpPWpGaD
Ibuprofen—CXCL8—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000423	0.0183	CbGpPWpGaD
Ibuprofen—PLAT—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	0.000333	0.0144	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.000332	0.0144	CbGpPWpGaD
Ibuprofen—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000317	0.159	CbGdCrCtD
Ibuprofen—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000312	0.156	CbGdCrCtD
Ibuprofen—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000312	0.156	CbGdCrCtD
Ibuprofen—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000305	0.153	CbGdCrCtD
Ibuprofen—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.000288	0.0125	CbGpPWpGaD
Ibuprofen—BCL2—FAS pathway and Stress induction of HSP regulation—IL1A—ankylosing spondylitis	0.000279	0.0121	CbGpPWpGaD
Ibuprofen—PLAT—Folate Metabolism—CRP—ankylosing spondylitis	0.000271	0.0117	CbGpPWpGaD
Ibuprofen—PLAT—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000266	0.0116	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000263	0.0114	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-C—ankylosing spondylitis	0.000259	0.0112	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.000247	0.0107	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL17A—ankylosing spondylitis	0.000237	0.0103	CbGpPWpGaD
Ibuprofen—PTGS1—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000233	0.0101	CbGpPWpGaD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000232	0.0101	CbGpPWpGaD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00023	0.00995	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—ankylosing spondylitis	0.00023	0.00995	CbGpPWpGaD
Ibuprofen—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.000228	0.0099	CbGpPWpGaD
Ibuprofen—PLAT—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000223	0.00969	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL12B—ankylosing spondylitis	0.00022	0.00954	CbGpPWpGaD
Ibuprofen—PLAT—amb2 Integrin signaling—TNF—ankylosing spondylitis	0.000219	0.00948	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000215	0.00933	CbGpPWpGaD
Ibuprofen—BCL2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000199	0.00864	CbGpPWpGaD
Ibuprofen—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000192	0.0957	CbGdCrCtD
Ibuprofen—CXCL8—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000191	0.0083	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000189	0.00819	CbGpPWpGaD
Ibuprofen—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000188	0.0942	CbGdCrCtD
Ibuprofen—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000188	0.0942	CbGdCrCtD
Ibuprofen—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000185	0.00803	CbGpPWpGaD
Ibuprofen—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000184	0.092	CbGdCrCtD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000183	0.00792	CbGpPWpGaD
Ibuprofen—SLCO2B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000182	0.00788	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000179	0.00778	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—IL10—ankylosing spondylitis	0.000177	0.00768	CbGpPWpGaD
Ibuprofen—SLC22A11—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000165	0.00714	CbGpPWpGaD
Ibuprofen—CXCL8—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000164	0.00712	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL1A—ankylosing spondylitis	0.000162	0.00701	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—CD40LG—ankylosing spondylitis	0.000161	0.00697	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—IL10—ankylosing spondylitis	0.000161	0.00697	CbGpPWpGaD
Ibuprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000157	0.00681	CbGpPWpGaD
Ibuprofen—CXCL8—AP-1 transcription factor network—HLA-A—ankylosing spondylitis	0.000156	0.00677	CbGpPWpGaD
Ibuprofen—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.000155	0.00672	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-B—ankylosing spondylitis	0.000153	0.00663	CbGpPWpGaD
Ibuprofen—PLAT—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	0.000151	0.00653	CbGpPWpGaD
Ibuprofen—CXCL8—Allograft Rejection—HLA-A—ankylosing spondylitis	0.000142	0.00615	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.00014	0.00607	CbGpPWpGaD
Ibuprofen—PPARG—Transcription factor regulation in adipogenesis—TNF—ankylosing spondylitis	0.000134	0.00581	CbGpPWpGaD
Ibuprofen—BCL2—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000134	0.00581	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.00013	0.00565	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—IL1A—ankylosing spondylitis	0.000129	0.00559	CbGpPWpGaD
Ibuprofen—CXCL8—Senescence and Autophagy in Cancer—IL1A—ankylosing spondylitis	0.000129	0.00559	CbGpPWpGaD
Ibuprofen—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.000128	0.00555	CbGpPWpGaD
Ibuprofen—SLC22A8—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000126	0.00544	CbGpPWpGaD
Ibuprofen—PLAT—Folate Metabolism—TNF—ankylosing spondylitis	0.000123	0.00531	CbGpPWpGaD
Ibuprofen—ABCC4—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00012	0.00522	CbGpPWpGaD
Ibuprofen—BCL2—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.000119	0.00518	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000117	0.00509	CbGpPWpGaD
Ibuprofen—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.000117	0.00509	CbGpPWpGaD
Ibuprofen—CXCL8—Corticotropin-releasing hormone—TLR4—ankylosing spondylitis	0.000115	0.00498	CbGpPWpGaD
Ibuprofen—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—ankylosing spondylitis	0.000114	0.00496	CbGpPWpGaD
Ibuprofen—SLCO1A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000111	0.00483	CbGpPWpGaD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000106	0.00458	CbGpPWpGaD
Ibuprofen—PTGS1—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000106	0.00458	CbGpPWpGaD
Ibuprofen—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—ankylosing spondylitis	0.000106	0.00458	CbGpPWpGaD
Ibuprofen—SLC22A6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000105	0.00454	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000102	0.00441	CbGpPWpGaD
Ibuprofen—ABCC1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0001	0.00435	CbGpPWpGaD
Ibuprofen—PLAT—Selenium Micronutrient Network—TNF—ankylosing spondylitis	9.74e-05	0.00422	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—KIR3DL1—ankylosing spondylitis	9.69e-05	0.0042	CbGpPWpGaD
Ibuprofen—BCL2—Ceramide signaling pathway—TNF—ankylosing spondylitis	9.49e-05	0.00412	CbGpPWpGaD
Ibuprofen—CXCL8—Spinal Cord Injury—TLR4—ankylosing spondylitis	9.41e-05	0.00408	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	9.39e-05	0.00407	CbGpPWpGaD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	9.33e-05	0.00405	CbGpPWpGaD
Ibuprofen—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	9.25e-05	0.00401	CbGpPWpGaD
Ibuprofen—CXCL8—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	8.83e-05	0.00383	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—CARD9—ankylosing spondylitis	8.74e-05	0.00379	CbGpPWpGaD
Ibuprofen—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	8.39e-05	0.00364	CbGpPWpGaD
Ibuprofen—BCL2—Caspase Cascade in Apoptosis—TNF—ankylosing spondylitis	8.27e-05	0.00359	CbGpPWpGaD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	8.25e-05	0.00358	CbGpPWpGaD
Ibuprofen—CXCL8—Cellular Senescence—IL1A—ankylosing spondylitis	8.16e-05	0.00354	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—HLA-C—ankylosing spondylitis	8.03e-05	0.00348	CbGpPWpGaD
Ibuprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	7.99e-05	0.00346	CbGpPWpGaD
Ibuprofen—Vertigo—Betamethasone—ankylosing spondylitis	7.56e-05	0.000981	CcSEcCtD
Ibuprofen—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	7.55e-05	0.00098	CcSEcCtD
Ibuprofen—Syncope—Dexamethasone—ankylosing spondylitis	7.54e-05	0.000979	CcSEcCtD
Ibuprofen—Syncope—Betamethasone—ankylosing spondylitis	7.54e-05	0.000979	CcSEcCtD
Ibuprofen—Arrhythmia—Prednisone—ankylosing spondylitis	7.52e-05	0.000975	CcSEcCtD
Ibuprofen—Infection—Triamcinolone—ankylosing spondylitis	7.52e-05	0.000975	CcSEcCtD
Ibuprofen—Sweating—Methotrexate—ankylosing spondylitis	7.51e-05	0.000975	CcSEcCtD
Ibuprofen—Infection—Methylprednisolone—ankylosing spondylitis	7.5e-05	0.000973	CcSEcCtD
Ibuprofen—Haematuria—Methotrexate—ankylosing spondylitis	7.47e-05	0.000969	CcSEcCtD
Ibuprofen—Shock—Triamcinolone—ankylosing spondylitis	7.44e-05	0.000966	CcSEcCtD
Ibuprofen—Insomnia—Prednisolone—ankylosing spondylitis	7.44e-05	0.000966	CcSEcCtD
Ibuprofen—Alopecia—Prednisone—ankylosing spondylitis	7.43e-05	0.000965	CcSEcCtD
Ibuprofen—Shock—Methylprednisolone—ankylosing spondylitis	7.43e-05	0.000964	CcSEcCtD
Ibuprofen—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	7.41e-05	0.000961	CcSEcCtD
Ibuprofen—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	7.4e-05	0.000961	CcSEcCtD
Ibuprofen—Loss of consciousness—Dexamethasone—ankylosing spondylitis	7.39e-05	0.000959	CcSEcCtD
Ibuprofen—Loss of consciousness—Betamethasone—ankylosing spondylitis	7.39e-05	0.000959	CcSEcCtD
Ibuprofen—Epistaxis—Methotrexate—ankylosing spondylitis	7.39e-05	0.000959	CcSEcCtD
Ibuprofen—Paraesthesia—Prednisolone—ankylosing spondylitis	7.39e-05	0.000959	CcSEcCtD
Ibuprofen—Tachycardia—Triamcinolone—ankylosing spondylitis	7.38e-05	0.000958	CcSEcCtD
Ibuprofen—Mental disorder—Prednisone—ankylosing spondylitis	7.37e-05	0.000957	CcSEcCtD
Ibuprofen—Tachycardia—Methylprednisolone—ankylosing spondylitis	7.37e-05	0.000956	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—IL17A—ankylosing spondylitis	7.35e-05	0.00319	CbGpPWpGaD
Ibuprofen—Skin disorder—Methylprednisolone—ankylosing spondylitis	7.33e-05	0.000951	CcSEcCtD
Ibuprofen—Malnutrition—Prednisone—ankylosing spondylitis	7.32e-05	0.00095	CcSEcCtD
Ibuprofen—Erythema—Prednisone—ankylosing spondylitis	7.32e-05	0.00095	CcSEcCtD
Ibuprofen—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	7.31e-05	0.000949	CcSEcCtD
Ibuprofen—Agranulocytosis—Methotrexate—ankylosing spondylitis	7.31e-05	0.000949	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	7.3e-05	0.000947	CcSEcCtD
Ibuprofen—Convulsion—Betamethasone—ankylosing spondylitis	7.29e-05	0.000946	CcSEcCtD
Ibuprofen—Convulsion—Dexamethasone—ankylosing spondylitis	7.29e-05	0.000946	CcSEcCtD
Ibuprofen—Hypertension—Betamethasone—ankylosing spondylitis	7.26e-05	0.000942	CcSEcCtD
Ibuprofen—Hypertension—Dexamethasone—ankylosing spondylitis	7.26e-05	0.000942	CcSEcCtD
Ibuprofen—Myalgia—Dexamethasone—ankylosing spondylitis	7.16e-05	0.000929	CcSEcCtD
Ibuprofen—Myalgia—Betamethasone—ankylosing spondylitis	7.16e-05	0.000929	CcSEcCtD
Ibuprofen—Anxiety—Dexamethasone—ankylosing spondylitis	7.14e-05	0.000926	CcSEcCtD
Ibuprofen—Anxiety—Betamethasone—ankylosing spondylitis	7.14e-05	0.000926	CcSEcCtD
Ibuprofen—Discomfort—Betamethasone—ankylosing spondylitis	7.07e-05	0.000918	CcSEcCtD
Ibuprofen—Discomfort—Dexamethasone—ankylosing spondylitis	7.07e-05	0.000918	CcSEcCtD
Ibuprofen—Haemoglobin—Methotrexate—ankylosing spondylitis	7.07e-05	0.000917	CcSEcCtD
Ibuprofen—Hypotension—Methylprednisolone—ankylosing spondylitis	7.05e-05	0.000915	CcSEcCtD
Ibuprofen—Hepatitis—Methotrexate—ankylosing spondylitis	7.03e-05	0.000913	CcSEcCtD
Ibuprofen—Haemorrhage—Methotrexate—ankylosing spondylitis	7.03e-05	0.000913	CcSEcCtD
Ibuprofen—Pharyngitis—Methotrexate—ankylosing spondylitis	6.98e-05	0.000906	CcSEcCtD
Ibuprofen—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	6.95e-05	0.00301	CbGpPWpGaD
Ibuprofen—Urinary tract disorder—Methotrexate—ankylosing spondylitis	6.94e-05	0.000901	CcSEcCtD
Ibuprofen—Vision blurred—Prednisone—ankylosing spondylitis	6.9e-05	0.000896	CcSEcCtD
Ibuprofen—Urethral disorder—Methotrexate—ankylosing spondylitis	6.89e-05	0.000895	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	6.89e-05	0.000894	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	6.88e-05	0.000892	CcSEcCtD
Ibuprofen—Oedema—Dexamethasone—ankylosing spondylitis	6.86e-05	0.000891	CcSEcCtD
Ibuprofen—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	6.86e-05	0.000891	CcSEcCtD
Ibuprofen—Anaphylactic shock—Betamethasone—ankylosing spondylitis	6.86e-05	0.000891	CcSEcCtD
Ibuprofen—Oedema—Betamethasone—ankylosing spondylitis	6.86e-05	0.000891	CcSEcCtD
Ibuprofen—PTGS1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	6.85e-05	0.00297	CbGpPWpGaD
Ibuprofen—Insomnia—Triamcinolone—ankylosing spondylitis	6.84e-05	0.000888	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—IL12B—ankylosing spondylitis	6.83e-05	0.00296	CbGpPWpGaD
Ibuprofen—Insomnia—Methylprednisolone—ankylosing spondylitis	6.83e-05	0.000886	CcSEcCtD
Ibuprofen—Infection—Betamethasone—ankylosing spondylitis	6.82e-05	0.000885	CcSEcCtD
Ibuprofen—Infection—Dexamethasone—ankylosing spondylitis	6.82e-05	0.000885	CcSEcCtD
Ibuprofen—ALB—Vitamin B12 Metabolism—CRP—ankylosing spondylitis	6.8e-05	0.00295	CbGpPWpGaD
Ibuprofen—Ill-defined disorder—Prednisone—ankylosing spondylitis	6.8e-05	0.000882	CcSEcCtD
Ibuprofen—Paraesthesia—Triamcinolone—ankylosing spondylitis	6.79e-05	0.000882	CcSEcCtD
Ibuprofen—Feeling abnormal—Prednisolone—ankylosing spondylitis	6.78e-05	0.00088	CcSEcCtD
Ibuprofen—Paraesthesia—Methylprednisolone—ankylosing spondylitis	6.78e-05	0.00088	CcSEcCtD
Ibuprofen—Visual impairment—Methotrexate—ankylosing spondylitis	6.78e-05	0.000879	CcSEcCtD
Ibuprofen—Anaemia—Prednisone—ankylosing spondylitis	6.77e-05	0.000879	CcSEcCtD
Ibuprofen—Shock—Dexamethasone—ankylosing spondylitis	6.75e-05	0.000876	CcSEcCtD
Ibuprofen—Shock—Betamethasone—ankylosing spondylitis	6.75e-05	0.000876	CcSEcCtD
Ibuprofen—Dyspnoea—Triamcinolone—ankylosing spondylitis	6.74e-05	0.000875	CcSEcCtD
Ibuprofen—Nervous system disorder—Betamethasone—ankylosing spondylitis	6.73e-05	0.000874	CcSEcCtD
Ibuprofen—Nervous system disorder—Dexamethasone—ankylosing spondylitis	6.73e-05	0.000874	CcSEcCtD
Ibuprofen—Agitation—Prednisone—ankylosing spondylitis	6.73e-05	0.000873	CcSEcCtD
Ibuprofen—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	6.72e-05	0.000872	CcSEcCtD
Ibuprofen—Thrombocytopenia—Betamethasone—ankylosing spondylitis	6.72e-05	0.000872	CcSEcCtD
Ibuprofen—Tachycardia—Dexamethasone—ankylosing spondylitis	6.7e-05	0.000869	CcSEcCtD
Ibuprofen—Tachycardia—Betamethasone—ankylosing spondylitis	6.7e-05	0.000869	CcSEcCtD
Ibuprofen—Angioedema—Prednisone—ankylosing spondylitis	6.69e-05	0.000869	CcSEcCtD
Ibuprofen—Dyspepsia—Triamcinolone—ankylosing spondylitis	6.66e-05	0.000864	CcSEcCtD
Ibuprofen—Erythema multiforme—Methotrexate—ankylosing spondylitis	6.65e-05	0.000863	CcSEcCtD
Ibuprofen—Dyspepsia—Methylprednisolone—ankylosing spondylitis	6.64e-05	0.000862	CcSEcCtD
Ibuprofen—Hyperhidrosis—Betamethasone—ankylosing spondylitis	6.64e-05	0.000861	CcSEcCtD
Ibuprofen—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	6.64e-05	0.000861	CcSEcCtD
Ibuprofen—Malaise—Prednisone—ankylosing spondylitis	6.6e-05	0.000857	CcSEcCtD
Ibuprofen—Vertigo—Prednisone—ankylosing spondylitis	6.58e-05	0.000854	CcSEcCtD
Ibuprofen—Syncope—Prednisone—ankylosing spondylitis	6.57e-05	0.000852	CcSEcCtD
Ibuprofen—Tinnitus—Methotrexate—ankylosing spondylitis	6.56e-05	0.000851	CcSEcCtD
Ibuprofen—Anorexia—Betamethasone—ankylosing spondylitis	6.54e-05	0.000849	CcSEcCtD
Ibuprofen—Anorexia—Dexamethasone—ankylosing spondylitis	6.54e-05	0.000849	CcSEcCtD
Ibuprofen—Urticaria—Prednisolone—ankylosing spondylitis	6.53e-05	0.000848	CcSEcCtD
Ibuprofen—Fatigue—Triamcinolone—ankylosing spondylitis	6.52e-05	0.000846	CcSEcCtD
Ibuprofen—Fatigue—Methylprednisolone—ankylosing spondylitis	6.51e-05	0.000845	CcSEcCtD
Ibuprofen—Loss of consciousness—Prednisone—ankylosing spondylitis	6.44e-05	0.000835	CcSEcCtD
Ibuprofen—Hypotension—Dexamethasone—ankylosing spondylitis	6.41e-05	0.000832	CcSEcCtD
Ibuprofen—Hypotension—Betamethasone—ankylosing spondylitis	6.41e-05	0.000832	CcSEcCtD
Ibuprofen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	6.39e-05	0.00277	CbGpPWpGaD
Ibuprofen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—ankylosing spondylitis	6.39e-05	0.00277	CbGpPWpGaD
Ibuprofen—Immune system disorder—Methotrexate—ankylosing spondylitis	6.35e-05	0.000824	CcSEcCtD
Ibuprofen—Convulsion—Prednisone—ankylosing spondylitis	6.35e-05	0.000824	CcSEcCtD
Ibuprofen—Mediastinal disorder—Methotrexate—ankylosing spondylitis	6.34e-05	0.000822	CcSEcCtD
Ibuprofen—Hypertension—Prednisone—ankylosing spondylitis	6.32e-05	0.000821	CcSEcCtD
Ibuprofen—Chills—Methotrexate—ankylosing spondylitis	6.31e-05	0.000819	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	6.25e-05	0.000812	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	6.25e-05	0.000812	CcSEcCtD
Ibuprofen—CXCL8—Metabolism of proteins—B3GNT2—ankylosing spondylitis	6.24e-05	0.0027	CbGpPWpGaD
Ibuprofen—Arthralgia—Prednisone—ankylosing spondylitis	6.24e-05	0.000809	CcSEcCtD
Ibuprofen—Myalgia—Prednisone—ankylosing spondylitis	6.24e-05	0.000809	CcSEcCtD
Ibuprofen—Feeling abnormal—Triamcinolone—ankylosing spondylitis	6.23e-05	0.000809	CcSEcCtD
Ibuprofen—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	6.22e-05	0.000807	CcSEcCtD
Ibuprofen—Anxiety—Prednisone—ankylosing spondylitis	6.21e-05	0.000806	CcSEcCtD
Ibuprofen—Alopecia—Methotrexate—ankylosing spondylitis	6.21e-05	0.000806	CcSEcCtD
Ibuprofen—Insomnia—Dexamethasone—ankylosing spondylitis	6.21e-05	0.000806	CcSEcCtD
Ibuprofen—Insomnia—Betamethasone—ankylosing spondylitis	6.21e-05	0.000806	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	6.19e-05	0.000804	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	6.17e-05	0.000801	CcSEcCtD
Ibuprofen—Paraesthesia—Dexamethasone—ankylosing spondylitis	6.16e-05	0.0008	CcSEcCtD
Ibuprofen—Paraesthesia—Betamethasone—ankylosing spondylitis	6.16e-05	0.0008	CcSEcCtD
Ibuprofen—CXCL8—Cellular responses to stress—IL1A—ankylosing spondylitis	6.16e-05	0.00267	CbGpPWpGaD
Ibuprofen—Discomfort—Prednisone—ankylosing spondylitis	6.16e-05	0.0008	CcSEcCtD
Ibuprofen—Mental disorder—Methotrexate—ankylosing spondylitis	6.16e-05	0.000799	CcSEcCtD
Ibuprofen—CXCL8—Allograft Rejection—TNF—ankylosing spondylitis	6.12e-05	0.00265	CbGpPWpGaD
Ibuprofen—Erythema—Methotrexate—ankylosing spondylitis	6.12e-05	0.000794	CcSEcCtD
Ibuprofen—Malnutrition—Methotrexate—ankylosing spondylitis	6.12e-05	0.000794	CcSEcCtD
Ibuprofen—CXCL8—GPCR ligand binding—PTGER4—ankylosing spondylitis	6.08e-05	0.00264	CbGpPWpGaD
Ibuprofen—BCL2—Apoptosis—TNF—ankylosing spondylitis	6.07e-05	0.00263	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Prednisolone—ankylosing spondylitis	6.06e-05	0.000787	CcSEcCtD
Ibuprofen—Dyspepsia—Dexamethasone—ankylosing spondylitis	6.04e-05	0.000784	CcSEcCtD
Ibuprofen—Dyspepsia—Betamethasone—ankylosing spondylitis	6.04e-05	0.000784	CcSEcCtD
Ibuprofen—Urticaria—Triamcinolone—ankylosing spondylitis	6.01e-05	0.00078	CcSEcCtD
Ibuprofen—Urticaria—Methylprednisolone—ankylosing spondylitis	6e-05	0.000778	CcSEcCtD
Ibuprofen—Dysgeusia—Methotrexate—ankylosing spondylitis	5.99e-05	0.000778	CcSEcCtD
Ibuprofen—Oedema—Prednisone—ankylosing spondylitis	5.98e-05	0.000776	CcSEcCtD
Ibuprofen—Anaphylactic shock—Prednisone—ankylosing spondylitis	5.98e-05	0.000776	CcSEcCtD
Ibuprofen—Abdominal pain—Methylprednisolone—ankylosing spondylitis	5.97e-05	0.000774	CcSEcCtD
Ibuprofen—Decreased appetite—Dexamethasone—ankylosing spondylitis	5.97e-05	0.000774	CcSEcCtD
Ibuprofen—Decreased appetite—Betamethasone—ankylosing spondylitis	5.97e-05	0.000774	CcSEcCtD
Ibuprofen—Infection—Prednisone—ankylosing spondylitis	5.94e-05	0.000771	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	5.93e-05	0.000769	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	5.93e-05	0.000769	CcSEcCtD
Ibuprofen—Fatigue—Betamethasone—ankylosing spondylitis	5.92e-05	0.000768	CcSEcCtD
Ibuprofen—Fatigue—Dexamethasone—ankylosing spondylitis	5.92e-05	0.000768	CcSEcCtD
Ibuprofen—Shock—Prednisone—ankylosing spondylitis	5.88e-05	0.000763	CcSEcCtD
Ibuprofen—UGT2B4—Metabolism—B3GNT2—ankylosing spondylitis	5.88e-05	0.00255	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL1R2—ankylosing spondylitis	5.87e-05	0.00254	CbGpPWpGaD
Ibuprofen—Nervous system disorder—Prednisone—ankylosing spondylitis	5.86e-05	0.000761	CcSEcCtD
Ibuprofen—Tachycardia—Prednisone—ankylosing spondylitis	5.83e-05	0.000757	CcSEcCtD
Ibuprofen—Skin disorder—Prednisone—ankylosing spondylitis	5.81e-05	0.000753	CcSEcCtD
Ibuprofen—Hyperhidrosis—Prednisone—ankylosing spondylitis	5.78e-05	0.00075	CcSEcCtD
Ibuprofen—Vision blurred—Methotrexate—ankylosing spondylitis	5.77e-05	0.000749	CcSEcCtD
Ibuprofen—Anorexia—Prednisone—ankylosing spondylitis	5.7e-05	0.000739	CcSEcCtD
Ibuprofen—Ill-defined disorder—Methotrexate—ankylosing spondylitis	5.68e-05	0.000737	CcSEcCtD
Ibuprofen—Anaemia—Methotrexate—ankylosing spondylitis	5.66e-05	0.000734	CcSEcCtD
Ibuprofen—Feeling abnormal—Betamethasone—ankylosing spondylitis	5.66e-05	0.000734	CcSEcCtD
Ibuprofen—Feeling abnormal—Dexamethasone—ankylosing spondylitis	5.66e-05	0.000734	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	5.61e-05	0.000728	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	5.61e-05	0.000728	CcSEcCtD
Ibuprofen—Hypersensitivity—Triamcinolone—ankylosing spondylitis	5.57e-05	0.000723	CcSEcCtD
Ibuprofen—BCL2—Immune System—ERAP1—ankylosing spondylitis	5.56e-05	0.00241	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	5.56e-05	0.000722	CcSEcCtD
Ibuprofen—ALB—Folate Metabolism—CRP—ankylosing spondylitis	5.53e-05	0.0024	CbGpPWpGaD
Ibuprofen—Malaise—Methotrexate—ankylosing spondylitis	5.52e-05	0.000716	CcSEcCtD
Ibuprofen—Vertigo—Methotrexate—ankylosing spondylitis	5.5e-05	0.000714	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—HLA-C—ankylosing spondylitis	5.49e-05	0.00238	CbGpPWpGaD
Ibuprofen—Leukopenia—Methotrexate—ankylosing spondylitis	5.48e-05	0.000711	CcSEcCtD
Ibuprofen—Urticaria—Betamethasone—ankylosing spondylitis	5.45e-05	0.000708	CcSEcCtD
Ibuprofen—Urticaria—Dexamethasone—ankylosing spondylitis	5.45e-05	0.000708	CcSEcCtD
Ibuprofen—ALB—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	5.45e-05	0.00236	CbGpPWpGaD
Ibuprofen—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	5.45e-05	0.000707	CcSEcCtD
Ibuprofen—Dizziness—Prednisolone—ankylosing spondylitis	5.44e-05	0.000706	CcSEcCtD
Ibuprofen—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	5.43e-05	0.00236	CbGpPWpGaD
Ibuprofen—Asthenia—Triamcinolone—ankylosing spondylitis	5.43e-05	0.000704	CcSEcCtD
Ibuprofen—Abdominal pain—Dexamethasone—ankylosing spondylitis	5.43e-05	0.000704	CcSEcCtD
Ibuprofen—Abdominal pain—Betamethasone—ankylosing spondylitis	5.43e-05	0.000704	CcSEcCtD
Ibuprofen—Asthenia—Methylprednisolone—ankylosing spondylitis	5.42e-05	0.000703	CcSEcCtD
Ibuprofen—Insomnia—Prednisone—ankylosing spondylitis	5.41e-05	0.000702	CcSEcCtD
Ibuprofen—Paraesthesia—Prednisone—ankylosing spondylitis	5.37e-05	0.000697	CcSEcCtD
Ibuprofen—Pruritus—Triamcinolone—ankylosing spondylitis	5.35e-05	0.000695	CcSEcCtD
Ibuprofen—Cough—Methotrexate—ankylosing spondylitis	5.34e-05	0.000693	CcSEcCtD
Ibuprofen—Pruritus—Methylprednisolone—ankylosing spondylitis	5.34e-05	0.000693	CcSEcCtD
Ibuprofen—PPARG—Signaling events mediated by HDAC Class I—TNF—ankylosing spondylitis	5.31e-05	0.0023	CbGpPWpGaD
Ibuprofen—Convulsion—Methotrexate—ankylosing spondylitis	5.3e-05	0.000688	CcSEcCtD
Ibuprofen—Dyspepsia—Prednisone—ankylosing spondylitis	5.26e-05	0.000683	CcSEcCtD
Ibuprofen—Arthralgia—Methotrexate—ankylosing spondylitis	5.21e-05	0.000676	CcSEcCtD
Ibuprofen—Myalgia—Methotrexate—ankylosing spondylitis	5.21e-05	0.000676	CcSEcCtD
Ibuprofen—Decreased appetite—Prednisone—ankylosing spondylitis	5.2e-05	0.000674	CcSEcCtD
Ibuprofen—Rash—Prednisolone—ankylosing spondylitis	5.19e-05	0.000673	CcSEcCtD
Ibuprofen—Dermatitis—Prednisolone—ankylosing spondylitis	5.18e-05	0.000672	CcSEcCtD
Ibuprofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	5.18e-05	0.000672	CcSEcCtD
Ibuprofen—Diarrhoea—Methylprednisolone—ankylosing spondylitis	5.16e-05	0.00067	CcSEcCtD
Ibuprofen—Fatigue—Prednisone—ankylosing spondylitis	5.15e-05	0.000669	CcSEcCtD
Ibuprofen—Headache—Prednisolone—ankylosing spondylitis	5.15e-05	0.000669	CcSEcCtD
Ibuprofen—Discomfort—Methotrexate—ankylosing spondylitis	5.15e-05	0.000668	CcSEcCtD
Ibuprofen—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	5.14e-05	0.00223	CbGpPWpGaD
Ibuprofen—Constipation—Prednisone—ankylosing spondylitis	5.11e-05	0.000663	CcSEcCtD
Ibuprofen—BCL2—Immune System—CARD9—ankylosing spondylitis	5.09e-05	0.00221	CbGpPWpGaD
Ibuprofen—Confusional state—Methotrexate—ankylosing spondylitis	5.04e-05	0.000654	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—IL1A—ankylosing spondylitis	5.02e-05	0.00218	CbGpPWpGaD
Ibuprofen—Dizziness—Triamcinolone—ankylosing spondylitis	5e-05	0.000649	CcSEcCtD
Ibuprofen—Anaphylactic shock—Methotrexate—ankylosing spondylitis	5e-05	0.000648	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—IL10—ankylosing spondylitis	5e-05	0.00217	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—CD40LG—ankylosing spondylitis	5e-05	0.00217	CbGpPWpGaD
Ibuprofen—Dizziness—Methylprednisolone—ankylosing spondylitis	4.99e-05	0.000648	CcSEcCtD
Ibuprofen—CXCL8—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	4.99e-05	0.00216	CbGpPWpGaD
Ibuprofen—Infection—Methotrexate—ankylosing spondylitis	4.96e-05	0.000644	CcSEcCtD
Ibuprofen—Feeling abnormal—Prednisone—ankylosing spondylitis	4.93e-05	0.000639	CcSEcCtD
Ibuprofen—Asthenia—Dexamethasone—ankylosing spondylitis	4.92e-05	0.000639	CcSEcCtD
Ibuprofen—Asthenia—Betamethasone—ankylosing spondylitis	4.92e-05	0.000639	CcSEcCtD
Ibuprofen—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—ankylosing spondylitis	4.92e-05	0.00213	CbGpPWpGaD
Ibuprofen—Nervous system disorder—Methotrexate—ankylosing spondylitis	4.9e-05	0.000636	CcSEcCtD
Ibuprofen—Thrombocytopenia—Methotrexate—ankylosing spondylitis	4.89e-05	0.000635	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Prednisone—ankylosing spondylitis	4.89e-05	0.000634	CcSEcCtD
Ibuprofen—Nausea—Prednisolone—ankylosing spondylitis	4.89e-05	0.000634	CcSEcCtD
Ibuprofen—Pruritus—Dexamethasone—ankylosing spondylitis	4.86e-05	0.00063	CcSEcCtD
Ibuprofen—Pruritus—Betamethasone—ankylosing spondylitis	4.86e-05	0.00063	CcSEcCtD
Ibuprofen—Skin disorder—Methotrexate—ankylosing spondylitis	4.85e-05	0.00063	CcSEcCtD
Ibuprofen—Hyperhidrosis—Methotrexate—ankylosing spondylitis	4.83e-05	0.000627	CcSEcCtD
Ibuprofen—Vomiting—Triamcinolone—ankylosing spondylitis	4.81e-05	0.000624	CcSEcCtD
Ibuprofen—Vomiting—Methylprednisolone—ankylosing spondylitis	4.8e-05	0.000623	CcSEcCtD
Ibuprofen—ABCB1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	4.77e-05	0.00207	CbGpPWpGaD
Ibuprofen—Rash—Triamcinolone—ankylosing spondylitis	4.77e-05	0.000619	CcSEcCtD
Ibuprofen—Dermatitis—Triamcinolone—ankylosing spondylitis	4.77e-05	0.000618	CcSEcCtD
Ibuprofen—Anorexia—Methotrexate—ankylosing spondylitis	4.76e-05	0.000618	CcSEcCtD
Ibuprofen—Rash—Methylprednisolone—ankylosing spondylitis	4.76e-05	0.000618	CcSEcCtD
Ibuprofen—Dermatitis—Methylprednisolone—ankylosing spondylitis	4.75e-05	0.000617	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—HLA-B—ankylosing spondylitis	4.75e-05	0.00206	CbGpPWpGaD
Ibuprofen—Urticaria—Prednisone—ankylosing spondylitis	4.75e-05	0.000616	CcSEcCtD
Ibuprofen—Headache—Triamcinolone—ankylosing spondylitis	4.74e-05	0.000615	CcSEcCtD
Ibuprofen—Headache—Methylprednisolone—ankylosing spondylitis	4.73e-05	0.000614	CcSEcCtD
Ibuprofen—Abdominal pain—Prednisone—ankylosing spondylitis	4.73e-05	0.000613	CcSEcCtD
Ibuprofen—Diarrhoea—Dexamethasone—ankylosing spondylitis	4.7e-05	0.000609	CcSEcCtD
Ibuprofen—Diarrhoea—Betamethasone—ankylosing spondylitis	4.7e-05	0.000609	CcSEcCtD
Ibuprofen—Hypotension—Methotrexate—ankylosing spondylitis	4.67e-05	0.000606	CcSEcCtD
Ibuprofen—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	4.55e-05	0.000591	CcSEcCtD
Ibuprofen—Dizziness—Betamethasone—ankylosing spondylitis	4.54e-05	0.000589	CcSEcCtD
Ibuprofen—Dizziness—Dexamethasone—ankylosing spondylitis	4.54e-05	0.000589	CcSEcCtD
Ibuprofen—Insomnia—Methotrexate—ankylosing spondylitis	4.52e-05	0.000586	CcSEcCtD
Ibuprofen—Nausea—Triamcinolone—ankylosing spondylitis	4.49e-05	0.000583	CcSEcCtD
Ibuprofen—Paraesthesia—Methotrexate—ankylosing spondylitis	4.49e-05	0.000582	CcSEcCtD
Ibuprofen—Nausea—Methylprednisolone—ankylosing spondylitis	4.48e-05	0.000582	CcSEcCtD
Ibuprofen—Dyspnoea—Methotrexate—ankylosing spondylitis	4.45e-05	0.000578	CcSEcCtD
Ibuprofen—CXCL8—Spinal Cord Injury—TNF—ankylosing spondylitis	4.44e-05	0.00193	CbGpPWpGaD
Ibuprofen—Somnolence—Methotrexate—ankylosing spondylitis	4.44e-05	0.000576	CcSEcCtD
Ibuprofen—Hypersensitivity—Prednisone—ankylosing spondylitis	4.4e-05	0.000572	CcSEcCtD
Ibuprofen—ABCB1—Allograft Rejection—HLA-A—ankylosing spondylitis	4.4e-05	0.00191	CbGpPWpGaD
Ibuprofen—Dyspepsia—Methotrexate—ankylosing spondylitis	4.4e-05	0.000571	CcSEcCtD
Ibuprofen—ALB—Selenium Micronutrient Network—CRP—ankylosing spondylitis	4.4e-05	0.00191	CbGpPWpGaD
Ibuprofen—Vomiting—Dexamethasone—ankylosing spondylitis	4.36e-05	0.000566	CcSEcCtD
Ibuprofen—Vomiting—Betamethasone—ankylosing spondylitis	4.36e-05	0.000566	CcSEcCtD
Ibuprofen—Decreased appetite—Methotrexate—ankylosing spondylitis	4.34e-05	0.000564	CcSEcCtD
Ibuprofen—Rash—Dexamethasone—ankylosing spondylitis	4.33e-05	0.000562	CcSEcCtD
Ibuprofen—Rash—Betamethasone—ankylosing spondylitis	4.33e-05	0.000562	CcSEcCtD
Ibuprofen—Dermatitis—Betamethasone—ankylosing spondylitis	4.32e-05	0.000561	CcSEcCtD
Ibuprofen—Dermatitis—Dexamethasone—ankylosing spondylitis	4.32e-05	0.000561	CcSEcCtD
Ibuprofen—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	4.31e-05	0.00056	CcSEcCtD
Ibuprofen—Fatigue—Methotrexate—ankylosing spondylitis	4.31e-05	0.000559	CcSEcCtD
Ibuprofen—Headache—Betamethasone—ankylosing spondylitis	4.3e-05	0.000558	CcSEcCtD
Ibuprofen—Headache—Dexamethasone—ankylosing spondylitis	4.3e-05	0.000558	CcSEcCtD
Ibuprofen—Asthenia—Prednisone—ankylosing spondylitis	4.29e-05	0.000557	CcSEcCtD
Ibuprofen—ABCC1—Disease—ANTXR2—ankylosing spondylitis	4.25e-05	0.00184	CbGpPWpGaD
Ibuprofen—Pruritus—Prednisone—ankylosing spondylitis	4.23e-05	0.000549	CcSEcCtD
Ibuprofen—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	4.13e-05	0.00179	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	4.12e-05	0.00179	CbGpPWpGaD
Ibuprofen—Feeling abnormal—Methotrexate—ankylosing spondylitis	4.12e-05	0.000534	CcSEcCtD
Ibuprofen—Diarrhoea—Prednisone—ankylosing spondylitis	4.09e-05	0.000531	CcSEcCtD
Ibuprofen—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	4.09e-05	0.00053	CcSEcCtD
Ibuprofen—Nausea—Dexamethasone—ankylosing spondylitis	4.08e-05	0.000529	CcSEcCtD
Ibuprofen—Nausea—Betamethasone—ankylosing spondylitis	4.08e-05	0.000529	CcSEcCtD
Ibuprofen—Urticaria—Methotrexate—ankylosing spondylitis	3.97e-05	0.000515	CcSEcCtD
Ibuprofen—Dizziness—Prednisone—ankylosing spondylitis	3.95e-05	0.000513	CcSEcCtD
Ibuprofen—Abdominal pain—Methotrexate—ankylosing spondylitis	3.95e-05	0.000512	CcSEcCtD
Ibuprofen—CXCL8—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	3.9e-05	0.00169	CbGpPWpGaD
Ibuprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	3.87e-05	0.00168	CbGpPWpGaD
Ibuprofen—Vomiting—Prednisone—ankylosing spondylitis	3.8e-05	0.000493	CcSEcCtD
Ibuprofen—Rash—Prednisone—ankylosing spondylitis	3.77e-05	0.000489	CcSEcCtD
Ibuprofen—Dermatitis—Prednisone—ankylosing spondylitis	3.77e-05	0.000489	CcSEcCtD
Ibuprofen—Headache—Prednisone—ankylosing spondylitis	3.74e-05	0.000486	CcSEcCtD
Ibuprofen—BCL2—Apoptosis—TNF—ankylosing spondylitis	3.72e-05	0.00161	CbGpPWpGaD
Ibuprofen—Hypersensitivity—Methotrexate—ankylosing spondylitis	3.68e-05	0.000478	CcSEcCtD
Ibuprofen—Asthenia—Methotrexate—ankylosing spondylitis	3.58e-05	0.000465	CcSEcCtD
Ibuprofen—CXCL8—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	3.55e-05	0.00154	CbGpPWpGaD
Ibuprofen—Nausea—Prednisone—ankylosing spondylitis	3.55e-05	0.000461	CcSEcCtD
Ibuprofen—Pruritus—Methotrexate—ankylosing spondylitis	3.53e-05	0.000459	CcSEcCtD
Ibuprofen—CXCL8—GPCR downstream signaling—PTGER4—ankylosing spondylitis	3.44e-05	0.00149	CbGpPWpGaD
Ibuprofen—Diarrhoea—Methotrexate—ankylosing spondylitis	3.42e-05	0.000444	CcSEcCtD
Ibuprofen—Dizziness—Methotrexate—ankylosing spondylitis	3.3e-05	0.000429	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—HLA-B—ankylosing spondylitis	3.24e-05	0.00141	CbGpPWpGaD
Ibuprofen—PPARG—Adipogenesis—TNF—ankylosing spondylitis	3.24e-05	0.0014	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—PTGER4—ankylosing spondylitis	3.2e-05	0.00139	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-C—ankylosing spondylitis	3.2e-05	0.00139	CbGpPWpGaD
Ibuprofen—Vomiting—Methotrexate—ankylosing spondylitis	3.18e-05	0.000412	CcSEcCtD
Ibuprofen—UGT1A3—Metabolism—B3GNT2—ankylosing spondylitis	3.15e-05	0.00137	CbGpPWpGaD
Ibuprofen—Rash—Methotrexate—ankylosing spondylitis	3.15e-05	0.000409	CcSEcCtD
Ibuprofen—Dermatitis—Methotrexate—ankylosing spondylitis	3.15e-05	0.000408	CcSEcCtD
Ibuprofen—BCL2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	3.14e-05	0.00136	CbGpPWpGaD
Ibuprofen—Headache—Methotrexate—ankylosing spondylitis	3.13e-05	0.000406	CcSEcCtD
Ibuprofen—CXCL8—Signaling by GPCR—PTGER4—ankylosing spondylitis	3.12e-05	0.00135	CbGpPWpGaD
Ibuprofen—PTGS1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	3.1e-05	0.00134	CbGpPWpGaD
Ibuprofen—ALB—Vitamin B12 Metabolism—TNF—ankylosing spondylitis	3.08e-05	0.00134	CbGpPWpGaD
Ibuprofen—Nausea—Methotrexate—ankylosing spondylitis	2.97e-05	0.000385	CcSEcCtD
Ibuprofen—BCL2—Innate Immune System—CRP—ankylosing spondylitis	2.87e-05	0.00124	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—ANTXR2—ankylosing spondylitis	2.85e-05	0.00124	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL1RN—ankylosing spondylitis	2.78e-05	0.0012	CbGpPWpGaD
Ibuprofen—BCL2—Innate Immune System—TLR4—ankylosing spondylitis	2.75e-05	0.00119	CbGpPWpGaD
Ibuprofen—UGT2B7—Metabolism—B3GNT2—ankylosing spondylitis	2.68e-05	0.00116	CbGpPWpGaD
Ibuprofen—PPARG—Metabolism—B3GNT2—ankylosing spondylitis	2.53e-05	0.0011	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—B3GNT2—ankylosing spondylitis	2.51e-05	0.00109	CbGpPWpGaD
Ibuprofen—ALB—Folate Metabolism—TNF—ankylosing spondylitis	2.51e-05	0.00109	CbGpPWpGaD
Ibuprofen—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	2.46e-05	0.00107	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD79A—ankylosing spondylitis	2.44e-05	0.00106	CbGpPWpGaD
Ibuprofen—SLCO1A2—Metabolism—B3GNT2—ankylosing spondylitis	2.33e-05	0.00101	CbGpPWpGaD
Ibuprofen—PLAT—Signaling Pathways—MMP3—ankylosing spondylitis	2.28e-05	0.000987	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling by GPCR—MMP3—ankylosing spondylitis	2.22e-05	0.000964	CbGpPWpGaD
Ibuprofen—UGT1A9—Metabolism—B3GNT2—ankylosing spondylitis	2.18e-05	0.000944	CbGpPWpGaD
Ibuprofen—UGT1A1—Metabolism—B3GNT2—ankylosing spondylitis	2.18e-05	0.000944	CbGpPWpGaD
Ibuprofen—ABCC1—Metabolism—B3GNT2—ankylosing spondylitis	2.1e-05	0.00091	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—IL1A—ankylosing spondylitis	2e-05	0.000866	CbGpPWpGaD
Ibuprofen—ALB—Selenium Micronutrient Network—TNF—ankylosing spondylitis	1.99e-05	0.000863	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CD40LG—ankylosing spondylitis	1.99e-05	0.000861	CbGpPWpGaD
Ibuprofen—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	1.95e-05	0.000844	CbGpPWpGaD
Ibuprofen—ABCB1—Allograft Rejection—TNF—ankylosing spondylitis	1.9e-05	0.000824	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-B—ankylosing spondylitis	1.89e-05	0.000819	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—PTGER4—ankylosing spondylitis	1.84e-05	0.0008	CbGpPWpGaD
Ibuprofen—PTGS1—Metabolism—B3GNT2—ankylosing spondylitis	1.77e-05	0.000769	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—HLA-A—ankylosing spondylitis	1.75e-05	0.000759	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—B3GNT2—ankylosing spondylitis	1.68e-05	0.000729	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—CRP—ankylosing spondylitis	1.67e-05	0.000724	CbGpPWpGaD
Ibuprofen—BCL2—Immune System—TLR4—ankylosing spondylitis	1.6e-05	0.000694	CbGpPWpGaD
Ibuprofen—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	1.41e-05	0.000611	CbGpPWpGaD
Ibuprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.32e-05	0.000574	CbGpPWpGaD
Ibuprofen—CXCL8—Signaling Pathways—MMP3—ankylosing spondylitis	1.31e-05	0.000569	CbGpPWpGaD
Ibuprofen—CYP2C8—Metabolism—B3GNT2—ankylosing spondylitis	1.15e-05	0.000497	CbGpPWpGaD
Ibuprofen—ALB—Metabolism—B3GNT2—ankylosing spondylitis	1.14e-05	0.000494	CbGpPWpGaD
Ibuprofen—PPARG—Developmental Biology—TNF—ankylosing spondylitis	1.11e-05	0.000482	CbGpPWpGaD
Ibuprofen—CYP2C19—Metabolism—B3GNT2—ankylosing spondylitis	1.02e-05	0.000444	CbGpPWpGaD
Ibuprofen—ABCC1—Disease—HLA-A—ankylosing spondylitis	1.01e-05	0.00044	CbGpPWpGaD
Ibuprofen—ABCB1—Metabolism—B3GNT2—ankylosing spondylitis	9.98e-06	0.000433	CbGpPWpGaD
Ibuprofen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	9.38e-06	0.000407	CbGpPWpGaD
Ibuprofen—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	9.33e-06	0.000404	CbGpPWpGaD
Ibuprofen—PTGS2—Disease—HLA-A—ankylosing spondylitis	6.81e-06	0.000295	CbGpPWpGaD
